FBT

First Trust NYSE Arca Biotechnology Index Fund

$199.69

+0.00%

Market closed. Last update: 10:57 PM ET

📎 Investment Objective

The First Trust NYSE Arca Biotechnology Index Fund (FBT) seeks to track the performance of the NYSE Arca Biotechnology Index, which is designed to measure the performance of companies in the biotechnology industry.

Overview

ETF tracking First Trust NYSE Arca Biotechnology Index Fund

Category Technology

Issuer First Trust

Inception Date 2008-11-06

Market Cap $1.2B

Average Volume N/A

Dividend Yield 0.59%

52-Week Range $145.67 - $203.02

VWAP $199.99

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

🎯 Investment Strategy

The fund invests at least 90% of its net assets in the common stocks and depositary receipts that comprise the NYSE Arca Biotechnology Index. The index is composed of biotechnology companies listed on major U.S. exchanges.

✨ Key Features

Provides exposure to the biotechnology industry through a diversified portfolio of stocks
Tracks the NYSE Arca Biotechnology Index, a benchmark for the biotechnology sector
Low expense ratio of 0.00%
Suitable for investors seeking targeted exposure to the biotechnology industry

⚠️ Primary Risks

Concentration risk as the fund is focused on the biotechnology sector
Volatility risk as biotechnology stocks can experience significant price swings
Regulatory risk as the biotechnology industry is heavily influenced by government policies and approvals
Competitive risk as companies in the sector face intense competition and rapid technological changes

👤 Best For

This ETF may be suitable for investors with a long-term investment horizon who are looking to gain exposure to the biotechnology industry as part of a diversified portfolio. Investors should be comfortable with the higher volatility and risks associated with the biotechnology sector.